以色列衛生部事實上對加強劑後的不良反應事件做了一個調查
The Israeli Ministry of Health Actually Did a Survey of Adverse Events after The Booster Dose
And it's absolutely devastating to the vaccine program
而這對疫苗項目絕對是毀滅性的好驚奇，驚奇。 以色列衛生部 (MoH) 對大約 2,000 人進行了實際上的調查，關於他們在接種輝瑞/BioNTech 新冠疫苗第三劑（加強劑）後 3-4 週的情況，查詢他們接種疫苗後所經歷的不良反應事件。2月9日在網上只發佈給醫療人員而媒體保持緘默的結果對新冠疫苗項目和推動强制疫苗絕對是毀滅性的
Here are some of the most important takeaways from the survey. Further down I’ll present all the results and conclude with some discussion of unreported events:
以下是調查中最重要的一些內容(全文請進入連結閲讀)。再往下，我將介紹所有結果，並以對未報告的事件作一些討論結束：
0.5% of people reported hospitalization as a result of the adverse event they experienced. Not just the emergency room, but actually being hospitalized.
Israel has administered about 4.5 million booster doses so far, which equates to over 22,000 hospitalizations.
Over 92 million booster doses have been distributed in the U.S., which equates to 460,000 hospitalizations.
4.5% of respondents reported neurological problems (again, more women than men), including:
Bell’s Palsy (0.5%)
Blurred or disturbed vision (0.5%)
Seizures/Convulsions (0.15%)
Loss of consciousness (0.2%)
16% of these neurological problems occurred within an hour of vaccination, an additional 27% within 24 hours, and 47% were ongoing by the time of the survey 3-4 weeks after vaccination.
In the US, this translates to 460,000 cases of Bell’s Palsy and blurred or disturbed vision, 135,000 seizures and 180,000 people losing consciousness.
Have you ever heard of a vaccine that is associated with seizures in 0.15% of adults who take it — let alone one that is mandated by many colleges and workplaces?
About 25% of people with pre-existing auto-immune disorders, depression or anxiety reported a worsening of their symptoms following the booster. Five to ten percent of people with diabetes, hypertension, and lung & heart disease also reported a worsening of their condition.
Nearly 10% of women under age of 54 had disruptions to their menstrual cycle after the booster (apparently they did not ask women above this age). About half of those women reported that the problems persisted at the time of a follow-up interview, which was anywhere from 10-16 weeks after vaccination.
Of these, 31% sought medical treatment as a result and 9% were on medication for it.
Notably, 39% of these women reported similar disruptions following prior doses, of whom 1/3 (which is a little over 6% of all women under the age of 54) were still experiencing symptoms at the time of the 3rd dose. Given that the vast majority of vaccinated Israelis were “fully vaccinated” by the end of March and the booster campaign for that age group didn’t get into full swing until late August, this means that these women were likely experiencing these symptoms for somewhere between 4-months.
近 10% 的 54 歲以下女性在加強劑注射後月經週期中斷（明顯地他們沒有詢問這個年齡以上的女性）。大約一半的女性報告，在接種疫苗後 10 至 16 個星期的後續訪問時這些問題仍然存在
其中 31% 的人結果要尋求治療，而 9% 的人因此而接受藥物治療
值得注意的是，這些女性中有 39% 報告在前兩劑後出現類似的中斷，其中 1/3（略高於所有 54 歲以下的女性的 6%）在第 3 劑時仍然出現症狀。鑑於絕大多數接種疫苗的以色列人在 3 月底之前已“完全接種疫苗”，而針對該年齡組的加強劑疫苗接種活動直到 8 月下旬才全面展開，這意味著這些婦女可能會經歷這些症狀 4 至? 個月
~以色列疫苗不良反應事件報告系統低估了不良反應事件的程度有多嚴重呢？
~此報告沒有死亡數字, 因為未能找到死人接受調查
全文:
https://jackanapes.substack.com/p/the-israeli-ministry-of-health-actually-db7?utm_source=url
沒有留言:
發佈留言